FDA
approval
· 2020-03-02
FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
Summary
The FDA approved a supplemental application for SUBOXONE (buprenorphine/naloxone) submitted by Indivior Inc. The update covers the approved changes to the produ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE)